Molecular testing plays a critical role in protecting newborn health. Public health laboratories worldwide rely on sensitive, reliable tools to rapidly detect genetic and metabolic disorders in newborns.

Dried blood spots — the most common sample type — are often low-input and may contain inhibitors that reduce test performance. To meet these challenges, molecular tools must be tough, sensitive, and optimized for these complex workflows.

Quantabio supports advances in newborn screening by providing robust and highly sensitive amplification and extraction tools. Our PCR/qPCR chemistries, innovative DNA extraction reagents along with comprehensive next generation sequencing (NGS) reagents are designed for accuracy, speed, and reliability in high-throughput public health laboratories.

5 Reasons Why Newborn Screening Matters

1. It Enables Early Detection
   Newborn Screening (NBS) identifies rare but serious conditions before symptoms appear, giving families and healthcare providers a crucial head start in managing a child’s health.
2. It Helps Guide Early Intervention
   Timely results give clinicians and families the insight they need to act quickly, when treatments or management strategies are most effective.
3. It Supports Families with Answers and Options
   Receiving an early diagnosis helps families understand their child’s condition sooner, reducing uncertainty and allowing informed decisions about care and support.
4. It Reduces Healthcare Costs Over Time
   By identifying and addressing conditions early, NBS helps prevent medical crises, reducing long-term expenses for families and the healthcare system.
5. It Strengthens Public Health Outcomes
   Widespread screening helps track and manage rare diseases at the population level, fueling research, improving treatment protocols, and building a stronger health infrastructure for all.